Motif Neurotech
Houston, US · Founded 2022 · Delaware corporation · 12 known investors
Motif Neurotech develops a therapeutic brain-computer interface using minimally invasive neuromodulation to treat difficult-to-treat mental health conditions such as depression. The company builds implantable neurotechnology for patients with mental illness and is based in Houston, Texas.
Founders & leadership
Motif Neurotech was founded in 2022 by Sameer Sheth and Sunil Sheth.
SS
Sameer ShethinFounder
SS
Sunil ShethFounder
NH
Nick HalperinChief Operating Officer
SG
Steve GoetzinChief Technology Officer
AA
Anthony ArnoldNamed on SEC filing
Board
JR
TM
Thomas M. ShehabBoard director
Investors · 12
Arboretum VenturesAnn Arbor · $5M – $15M
PsyMed VenturesBerkeley
TMC Venture FundHouston
Capital FactoryreportedAustin
Divergent CapitalreportedNew York · $250K – $1M
Dolby Family Venturesreported · 3 sourcesSan Francisco
KdT VenturesreportedAustin · $500K – $3M
Prime Movers LabreportedJackson · $2M – $30Mvia Amy Kruse · board
re.Mind CapitalreportedLondon
Also in the syndicate · 3
Empath VenturesSatori NeuroTMC Innovation
Reported raises · per SEC filings
Form D private placements$15.3M disclosed across 1 round · 2024
▶$15.3MraisedJan 2024 · 28 investors · Other Health CareRule 506(b)
▶$15.3MraisedJan 2024 · 28 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Anthony ArnoldDirector
- Jacob RobinsonExecutive Officer, Director
- Thomas M. ShehabDirector
- Amy KruseDirector
- Offering amount
- $21.6M
- Amount sold
- $15.3M
- First sale
- Jan 2024
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 7
by search overlap
Blackrock Neurotech32 shared keywordsBlackrock Neurotech develops a neurotechnology platform, including brain-computer interface systems, aimed at improving patient lives and treating neurological conditions. It builds implantable neural interface technology for medical and research applications.
Neuralink29 shared keywordsNeurotechnology company developing implantable brain-computer interfaces for people with paralysis and vision loss.
Precision26 shared keywordsPrecision Neuroscience develops a minimally invasive, high-bandwidth brain-computer interface, including its Layer 7 cortical interface, initially aimed at helping people with paralysis control digital devices and robotics using their thoughts. The company works with hospital clinical partners on implanted studies and positions its technology as removable and upgradable without damaging the brain.
Neuroelectrics20 shared keywordsNeuroelectrics develops the Starstim platform, combining EEG monitoring headpieces, cloud-based delivery, and personalized protocols to deliver non-invasive Transcranial Electrical Stimulation (tES) neuromodulation therapy for brain disorders such as depression and epilepsy. It serves patients whose conditions are not controlled by drugs or surgery, as well as neuroscience researchers who use its tools for brain research.
Synchron19 shared keywordsSynchron develops brain-computer interface technology delivered via catheter to restore or improve motor and cognitive function in people with impairment or decline. The company serves patients with motor impairment and cognitive decline using a minimally invasive approach inspired by cardiac interventional procedures.
Pano AI19 shared keywordsPano develops artificial intelligence and machine learning technology solutions to help utility companies and fire agencies detect and manage wildfire threats. The company serves emergency managers and professionals in the utility and fire industries seeking to protect communities from wildfires.
Paradromics Turning Data Into Medicine19 shared keywordsParadromics develops a brain-computer interface (BCI) system, with FDA Breakthrough Device Designations for speech decoding and digital device control, and works with academic medical institutions on translational BCI research. The company builds implantable neurotechnology aimed at clinical applications.
Companies competing with Motif Neurotech for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Motif Neurotech do?
- Motif Neurotech develops a therapeutic brain-computer interface using minimally invasive neuromodulation to treat difficult-to-treat mental health conditions such as depression. The company builds implantable neurotechnology for patients with mental illness and is based in Houston, Texas.
- Who founded Motif Neurotech?
- Motif Neurotech was founded by Sameer Sheth, Sunil Sheth in 2022.
- Who are Motif Neurotech's investors?
- Motif Neurotech's investors include Arboretum Ventures, PsyMed Ventures, TMC Venture Fund, Capital Factory, Divergent Capital, Dolby Family Ventures, KdT Ventures, Prime Movers Lab and 1 more.
- How much funding has Motif Neurotech raised?
- Motif Neurotech has disclosed $15.3M raised across 1 round.
- Where is Motif Neurotech headquartered?
- Motif Neurotech is headquartered in Houston, US.